Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b900ce27fc2f34e9e5165bd07d2f0c73 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D413-14 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D413-14 |
filingDate |
2020-04-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fd2403b7669790692a949451ef023192 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_28f752919fb55f6da36139b1309ae8bb http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c3ee9a1127df60f6623d1f8490e31b53 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d28f8e7b1b792199040d5923080d2272 |
publicationDate |
2022-07-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-2022220102-A1 |
titleOfInvention |
D3 receptor agonist compounds; methods of preparation; intermediates thereof; and methods of use thereof |
abstract |
Disclosed herein are novel compounds including dopamine D 3 receptor agonists, compositions thereof, methods of use thereof, and processes of synthesizing the same. Further disclosed are D 3 R selective agonist compounds, specifically bitopic ligands comprising chirality. |
priorityDate |
2019-04-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |